PMID- 26518023 OWN - NLM STAT- MEDLINE DCOM- 20160829 LR - 20221207 IS - 1432-2072 (Electronic) IS - 0033-3158 (Linking) VI - 233 IP - 3 DP - 2016 Feb TI - Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population. PG - 435-45 LID - 10.1007/s00213-015-4124-6 [doi] AB - OBJECTIVE: Few studies have examined the potential interactive effect of both smoking and drinking on cognition. Brain-derived neurotrophic factor (BDNF) plays a critical role in cognition. This is the first study to examine the neurocognitive consequences of cigarette smoking combined with chronic alcohol consumption and their relationship to serum BDNF levels in a Chinese Han population. MATERIALS AND METHODS: We recruited 191 healthy male subjects, including 47 isolated smokers, 31 isolated chronic alcohol users, 58 combined smokers and chronic alcohol users, and 55 non-smokers and non-alcohol users. We then compared the repeatable battery for the assessment of neuropsychological status (RBANS) scores and serum BDNF levels in these four groups. RESULTS: When compared to the non-smoking + non-alcohol-using group, the smoking group performed worse on immediate memory, attention, language, and RBANS total score. There were no significant differences in the RBANS scores between the alcohol-using group and non-smoking + non-alcohol-using group, or between the smoking group and smoking + alcohol-using group. We did not find an association between BDNF and smoking or drinking status or between BDNF and cognitive performance. In the smoking group, there was a significant correlation between BDNF and carbon monoxide concentration, and between BDNF and the Fagerstrom Test for Nicotine Dependence (FTND) total score. CONCLUSIONS: Our results suggest that smoking is associated with cognitive decline, but not with BDNF levels in a normal population. However, smoking severity is positively associated with BDNF levels. Concomitant alcohol use does not worsen the cognitive decline caused by smoking. FAU - Zhang, Xiang Yang AU - Zhang XY AD - Beijing HuiLongGuan Hospital, Peking University, Beijing, China. zhangxy9@gmail.com. AD - Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA. zhangxy9@gmail.com. AD - UT Center of Excellence on Mood Disorders (UTCEMD), Biomedical and Behavioral Sciences Building, 1941 East Road, Houston, TX, 77054, USA. zhangxy9@gmail.com. FAU - Tan, Yun-Long AU - Tan YL AD - Beijing HuiLongGuan Hospital, Peking University, Beijing, China. FAU - Chen, Da-Chun AU - Chen DC AD - Beijing HuiLongGuan Hospital, Peking University, Beijing, China. FAU - Tan, Shu-Ping AU - Tan SP AD - Beijing HuiLongGuan Hospital, Peking University, Beijing, China. FAU - Yang, Fu-De AU - Yang FD AD - Beijing HuiLongGuan Hospital, Peking University, Beijing, China. FAU - Zunta-Soares, Giovana B AU - Zunta-Soares GB AD - Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA. FAU - Soares, Jair C AU - Soares JC AD - Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151030 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) RN - 7U1EE4V452 (Carbon Monoxide) SB - IM MH - Adult MH - Aged MH - Alcohol Drinking/*metabolism/*psychology MH - Asian People MH - Attention/drug effects MH - Brain-Derived Neurotrophic Factor/*blood MH - Carbon Monoxide/blood MH - China MH - Cognition/*drug effects MH - Humans MH - Language MH - Male MH - Memory/drug effects MH - Middle Aged MH - Neuropsychological Tests MH - Psychomotor Performance/drug effects MH - Smoking/*metabolism/*psychology MH - Tobacco Use Disorder/psychology MH - Young Adult OTO - NOTNLM OT - Alcohol OT - Brain-derived neurotrophic factor OT - Cognition OT - Nicotine OT - Smoking EDAT- 2015/11/01 06:00 MHDA- 2016/08/30 06:00 CRDT- 2015/11/01 06:00 PHST- 2015/07/12 00:00 [received] PHST- 2015/10/13 00:00 [accepted] PHST- 2015/11/01 06:00 [entrez] PHST- 2015/11/01 06:00 [pubmed] PHST- 2016/08/30 06:00 [medline] AID - 10.1007/s00213-015-4124-6 [pii] AID - 10.1007/s00213-015-4124-6 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2016 Feb;233(3):435-45. doi: 10.1007/s00213-015-4124-6. Epub 2015 Oct 30.